Skip to main content

Summary

for females ages 18 years and up (full criteria)
healthy people welcome
at San Francisco, California and other locations
study started
estimated completion:

Description

Summary

This is a research study to measure the effect of digoxin injection on Dilation and Evacuation (D&E) procedure duration. Digoxin is the most commonly used feticidal agent among family planning subspecialists, and is commonly used for a variety of reasons including provider preference, patient preference, and concerns over legal status of later D&E procedures. There have been several studies on digoxin administration, adverse effects, and impact on the D&E procedure, but doctors want to clarify how digoxin effects D&E procedure time, if at all.

Official Title

Intrafetal Digoxin as an Adjuvant for Dilation and Evacuation at 20 to 24 Weeks' Gestation: a Placebo-controlled, Double-blinded Randomized Controlled Trial

Keywords

Abortion Digoxin

Eligibility

You can join if…

Open to females ages 18 years and up

  • 20 weeks 0 days-24 weeks 0 days gestation
  • English or Spanish speaking
  • 18 years or older

You CAN'T join if...

  • Under 18
  • Contraindications to digoxin

Locations

  • SFGH Women's Options Center accepting new patients
    San Francisco, California, 94110, United States
  • FPA Women's Health accepting new patients
    Long Beach, California, 90806, United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT03136068
Phase
Phase 4
Lead Scientist
Jennifer Kerns
Study Type
Interventional
Last Updated
April 26, 2017
I’m interested in this study!